Purpose

The goals of this work will be to evaluate the preliminary efficacy of a comprehensive pre-dialysis education program on increased knowledge of conservative kidney management and advance care planning among patients with advanced CKD.

Conditions

Eligibility

Eligible Ages
Over 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Stage 4 or 5 CKD (defined by the CKD-EPI estimation of GFR < 30 ml/min/1.73m2) - Age 65 years or greater or frail - self-reported Black or White race

Exclusion Criteria

  • History of dementia - History of legal blindness - Listed for kidney transplantation

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Comprehensive pre-dialysis program incorporating conservative and advance care planning education
Primary Purpose
Health Services Research
Masking
Single (Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
No Intervention
Standard pre-dialysis education
Standard pre-dialysis options education including hemodialysis, peritoneal dialysis, and kidney transplantation
Active Comparator
ESRD education + ACP
Standard ESRD education + conservative kidney management and advance care planning education
  • Other: ESRD education + conservative kidney management and ACP education
    Targeted conservative kidney management and advance care planning education delivered in person by trained healthcare providers

More Details

Status
Terminated
Sponsor
University of Pennsylvania

Study Contact

Detailed Description

This intervention will be randomized among patients with advanced chronic kidney disease.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.